Background: Assessment of ovarian reserve is an essential parameter in the evaluation of female infertility. It has been established that serum anti-müllerian hormone (AMH) is the best marker of ovarian reserve and predicts the quality of ovarian response to stimulation. However, there is some controversy about the prediction of pregnancy rates. Can the serum AMH assay predict the chances of successful in vitro fertilization (IVF)? Objective: To analyze the association between AMH levels, the number of mature oocytes obtained by oocyte puncture after stimulation and the outcome of in vitro fertilization at the first attempt. Methods: An analytical cross-sectional study with retrospective data collection on 123 patients who had consulted for a desire to conceive and undergone ovarian reserve evaluation followed by IVF in the assisted reproduction department of the Poissy-Saint-Germain-en-Laye Intercommunal Hospital Centre at its Poissy hospital site between January 2020 and March 2022. Results: Of the 123 patients, 43.8% had normal AMH levels. At the end of stimulation, almost half of patients (52.84%) had a sub-optimal ovarian response and almost a quarter had a poor response (27.64%). We found a statistically significant positive correlation [r = 0.42 b = 0.70 CI 95% (0.43 - 0.97) p = 0.000] between AMH level and the number of mature oocytes collected. Of all patients with low AMH, 83.3% had a clinical pregnancy, while 61.1% of patients with normal AMH had no pregnancy. These differences were statistically significant (p = 0.001). AMH level was significantly associated with predicting ovarian response to stimulation and had a decreasing association with IVF outcome. Indeed, compared with patients with low AMH levels, those with normal AMH levels were 7 times more likely to have a good response to stimulation [OR = 7.12 CI 95% (1.98 - 30.79) p = 0.003] and less likely to achieve pregnancy after embryo transfer. Conclusion: AMH assay is an important marker of ovarian reserve and predicts ovarian response to stimulation. It correlates with the number of mature oocytes that can be collected at puncture but does not predict the chances of IVF pregnancy.
Cite this paper
Asana, A. M. , Esimo, J. M. , Kabengele, D. N. , Ilondo, G. L. , Mughole, A. M. , Sendeke, P. M. , Bapanzi, C. M. , Bikuelo, C. B. and Mata, J. M. (2024). Anti-Müllerian Hormone in the Prediction of Assisted Reproduction Results at the Poissy Hospital (France). Open Access Library Journal, 11, e1504. doi: http://dx.doi.org/10.4236/oalib.1111504.
Romero, E.S., Arqué, M., de Segura, R.G., Salvador, Z. and Gutton, I. (2020) Hormone anti-müllérienne (AMH): Valeurs de référence et fertilité. https://www.invitra.fr/hormone-antimullerienne-amh/
Boivin, J., Bunting, L., Collins, J.A. and Nygren, K.G. (2007) International Estimes of Infertility Prevalence and Treatment-Seeking: Potential Need and Demand for Infertility Medical Care. Human Reproduction, 22, 1506-1512. https://doi.org/10.1093/humrep/dem046
Asemota, O.A. and Klatsky, P. (2015) Acces to Infertility Care in Developping World: The Family Promotion Gap. Seminars in Reproductive Medicine, 33, 17-22. https://doi.org/10.1055/s-0034-1395274
Brzakowski, M., Lourdel, E., Cabry, R., Olieric, M.-F., Claeys, C., Devaux, A., et al. (2009) Epidemiologie du couple infertile. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 38, F3-F7. https://doi.org/10.1016/S0368-2315(09)70226-1
Dewailly, D. and Laven, J. (2019) AMH as the Primary Marker for Fertility. European Journal of Endocrinology, 181, D45-D51. https://doi.org/10.1530/EJE-19-0373
Rolland, A.-L. and Dewailly, D. (2015) Le dosage de l’AMH permet-il de prédire de façon fiable la fertilité féminine? Gynécologie Obstétrique & Fertilité, 43, 670-675. https://doi.org/10.1016/j.gyobfe.2015.08.004
Park, H.J., Lee, G.H., Gong, D.S., Yoon, T.K. and Lee, W.S. (2016) The Meaning of Anti-Mullerian Hormone Levels in Patients at a High Risk of Poor Ovarian Response. Clinical and Experimental Reproductive Medicine, 43, 139-145. https://doi.org/10.5653/cerm.2016.43.3.139
La Marca, A., Grisendi, V. and Griesinger, G. (2013) How Much Does AMH Really Vary in Normal Women? International Journal of Endocrinology, 2013, Article ID: 959487. https://doi.org/10.1155/2013/959487
Klinkert, E.R., Broekmans, F.J.M., Looman, C.W.N., Habbema, J.D.F. and Te Velde, E.R. (2005) The Antral Follicle Count Is a Better Marker than Basal Follicle-Stimulating Hormone for the Selection of Older Patients with Acceptable Pregnancy Prospects after in vitro Fertilization. Fertility and Sterility, 83, 811-814. https://doi.org/10.1016/j.fertnstert.2004.11.005
Hagen, C.P., Vestergaard, S., Juul, A., Niels, E.S., Andersson, A.M., Main, K.M., et al. (2012) Low Concentration of Circulating Antimullerian Hormone Is Not Predictive of Reduced Fecundability in Young Healthy Women: A Prospective Cohort Study. Fertility and Sterility, 98, 1602-1608. https://doi.org/10.1016/j.fertnstert.2012.08.008
Hazout, A., Bouchard, P., Seifer, D.B., Aussage, P., Junca, A.M. and Cohen-Bacrie, P. (2004) Serum Antimullerian an Hormone/Mullerian-Inhibiting Substance Appears to Be a More Discriminatory Marker of Assisted Reproductive Technology Outcome than Follicle-Stimulating Hormone, Inhibin B or Estradiol. Fertility and Sterility, 82, 1323-1329. https://doi.org/10.1016/j.fertnstert.2004.03.061
Fanchin, R., Louafi, N., Mendez Lozano, D.H., Frydman, R. and Taieb, J. (2005) Per-Follicle Measurements Indicate that Anti-Mullerian Hormone Secretion Is Modulated by the Extent of Follicular Development and Luteinization and May Reflect Qualitatively the Ovarian Follicular Status. Fertility and Sterility, 84, 167-173. https://doi.org/10.1016/j.fertnstert.2005.01.115
Lekamge, D.N., Barry, M., Kolo, M., Lane, M., Gilchrist, R.B. and Tremellen, K.P. (2007) Anti-Mullerian Hormone as a Predictor of IVF Outcome. Reproductive Biomedicine Online, 14, 602-610. https://doi.org/10.1016/S1472-6483(10)61053-X
Tian, H., Mao, X., Su, N. and La, X. (2021) The Correlation between AMH and Number of Embryos in POSEIDON Groups: A Retrospective Cohort Study. Reproductive Biomedicine Online, 42, 842-848. https://doi.org/10.1016/j.rbmo.2020.12.010
Broer, S.L., Mol, B.W.J., Hendriks, D. and Broekmans, F.J.M. (2009) The Role of Antimullerian Hormone in Prediction of Outcome after IVF: Comparison with the Antral Follicle Count. Fertility and Sterility, 91, 705-714. https://doi.org/10.1016/j.fertnstert.2007.12.013
Streuli, I., Cantero-Perez, P. and Miserez-Zaugg, C. (2013) Dosage sérique de l’hormone antimüllérienne en gynécologie: Indications et limites. Revue Médicale Suisse, 9, 1954-1958. https://doi.org/10.53738/REVMED.2013.9.403.1954
Mboloko, E., Nzau, N. and Lokengo, L. (2011) Itinéraire de la femme kinoise à la recherche des soins d’infertilité. Annales Africaines de Médecine, 4, 855-863.
Matthews, T.J. and Hamilton, B.E. (2009) Delayed Childbearing: More Women Are Having Their First Child Later in Life. NCHS Data Brief, 21, 1-8. https://doi.org/10.1037/e665262010-001
Institut National de la statistique et des études économiques (INSEE) (2022) Âge moyen des mères à l’accouchement, données annuelles de 1994 à 2021.
https://www.insee.fr/statitiques/2381394
Rosen, M.P., Johnstone, E., McCulloch, C.E., Schuh-Huerta, S.M., Sternfeld, B., Reijo-Pera, R.A., et al. (2012) A Characterization of the Relationship of Ovarian Reserve Markers with Age. Fertility and Sterility, 97, 238-243. https://doi.org/10.1016/j.fertnstert.2011.10.031
Leader, B. and Baker, V.L. (2014) Maximizing the Clinical Utility of Antimullerian Hormone Testing in Women’s Health. Current Opinion in Obstetrics and Gynecology, 26, 226-236. https://doi.org/10.1097/GCO.0000000000000087
Jeppesen, J.V., Anderson, R.A., Kelsey, T.W., Christiansen, S.L., Kristensen, S.G., Jayaprakasan, K., et al. (2013) Which Follicles Make the Most Anti-Mullerian Hormone in Humans? Evidence for an Abrupt Decline in AMH Production at the Time of Follicle Selection. Molecular Human Reproduction, 19, 519-527. https://doi.org/10.1093/molehr/gat024
Griesinger, G., Dafopoulos, K., Buendgen, N., Cascorbi, I., Georgoulias, P., Zavos, A., et al. (2012) Elimination Half-Life of Anti-Mullérian Hormone. The Journal of Clinical Endocrinology & Metabolism, 97, 2160-2163. https://doi.org/10.1210/jc.2012-1070
Victoria, M., Labrosse, J., Krief, F., Grynberg, M., Comtet, M. and Cédrin-Durnerin, I. (2019) Anti Müllerian Hormone: More than a Biomarker of Female Reproductive Function. Journal of Gynecology Obstetrics and Human Reproduction, 48, 19-24. https://doi.org/10.1016/j.jogoh.2018.10.015
Dewailly, D., andersen, C.Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., et al. (2014) The Physiology and Clinical Utility of Anti-Mullerian Hormone in Women. Human Reproduction Update, 20, 370-385. https://doi.org/10.1093/humupd/dmt062
Benaglia, L., Somigliana, E., Vercellini, P., Abbiati, A., Ragni, G. and Fedele, L. (2009) Endometriotic Ovarian Cysts Negatively Affect the Rate of Spontaneous Ovulation. Human Reproduction, 24, 2183-2186. https://doi.org/10.1093/humrep/dep202
Streuli, I., De Ziegler, D., Gayet, V., Santulli, P., Bijaoui, G., De Mouzon, J., et al. (2012) In Women with Endometriosis Anti-Mullerian Hormone Levels Are Decreased Only in Those with Previous Endometrioma Surgery. Human Reproduction, 27, 3294-3303. https://doi.org/10.1093/humrep/des274
Kawwass, J.F., Hipp, H.S., Session, D.R., Kissin, D.M., Jamieson, D.J. and National ART Surveillance System Group (2017) Severity of Diminished Ovarian Reserve and Chance of Success with Assisted Reproductive Technology. Journal of Reproductive Medicine, 62, 153-160.
